Improving Human Value and Quality of Life with Exosome

Our Exosomes Your Future

Improving Human Value and Quality of Life with Exosome

Our Exosomes Your Future

Improving Human Value and Quality of Life with Exosome

Our Exosomes Your Future

scroll
Exosome Global Leader
The world's first biotech company developing exosome-based cosmeceutical and biopharmaceutical products

R&D

Development of exosome-based new regenerative medicine and biomedicine

ExoSCRT Exosome

Regenerative
Therapeutics

Immuno-Oncology
Product
ExoSCRT exosomes, presenting a value beyond aesthetics
Bio-Ingredient
Development of exosome-based raw materials for next-generation cosmetics
ExoBRID-E
Vexosome
Rose Exosome
ExoSCRT™
Patent registration
No. 10-1895916

Production of high-purity & high-efficiency
exosome using ExoSCRT™,
our proprietary technology

VIEW MORE

Patent

VIEW MORE >>

Publication

VIEW MORE >>

Investor

VIEW MORE >>
ExoCoBio News
ExoCoBio’s Domestic & International News

Exocobio Launch ASCE+HRLV to Improv..
Exoco Bio (CEO Cho Byung-sung), which specializes in EXO-som, has launched a new product called ASCE

Application in Acute Kidney Injury
I published a paper on the a/ < trended beads >

Biotech companies leading the way wi..
Born2Invest, a digital news/ < born2invest >

Exosome redux
In December 2019, it was int/ < Nature Biotechnology >